Double PIK3CA mutations in cis increase oncogenicity and sensitivity to PI3Kα inhibitors Meeting Abstract


Authors: Vasan, N.; Razavi, P.; Johnson, J. L.; Shao, H.; Shah, H.; Antoine, A.; Ladewig, E.; Gorelick, A.; Lin, T. Y.; Toska, E.; Xu, G.; Kazmi, A.; Chang, M. T.; Taylor, B. S.; Dickler, M. N.; Jhaveri, K.; Chandarlapaty, S.; Rabadan, R.; Reznik, E.; Smith, M. L.; Sebra, R.; Schimmoller, F.; Wilson, T. R.; Friedman, L. S.; Cantley, L. C.; Scaltriti, M.; Baselga, J.
Abstract Title: Double PIK3CA mutations in cis increase oncogenicity and sensitivity to PI3Kα inhibitors
Meeting Title: 111th Annual Meeting of the American Association for Cancer Research (AACR)
Journal Title: Cancer Research
Volume: 80
Issue: 16 Suppl.
Meeting Dates: 2020 Apr 27-28/Jun 22-24
Meeting Location: Philadelphia, PA
ISSN: 0008-5472
Publisher: American Association for Cancer Research  
Date Published: 2020-08-01
Language: English
ACCESSION: WOS:000590059302406
DOI: 10.1158/1538-7445.Am2020-ng16
PROVIDER: wos
Notes: Meeting Abstract: NG16 -- Due to COVID-19 pandemic, the conference was held virtually -- Source: Wos
Altmetric
Citation Impact
BMJ Impact Analytics
MSK Authors
  1. Maura N Dickler
    263 Dickler
  2. Komal Lachhman Jhaveri
    219 Jhaveri
  3. Barry Stephen Taylor
    238 Taylor
  4. Erik Manfred Ladewig
    16 Ladewig
  5. Jose T Baselga
    484 Baselga
  6. Maurizio Scaltriti
    170 Scaltriti
  7. Eduard Reznik
    108 Reznik
  8. Pedram Razavi
    184 Razavi
  9. Eneda   Toska
    30 Toska
  10. Neil Vasan
    19 Vasan
  11. Guotai Xu
    14 Xu
  12. Hong Shao
    13 Shao
  13. Abiha Kazmi
    4 Kazmi